Company / EPS (Diluted)
KESTRA MEDICAL TECHNOLOGIES, LTD. EPS (Diluted) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$5.07
FY2025
5-year range
-$5.13 / -$5.07
FY2023-FY2025
Trend
+1.2%
vs FY2024
Sector context
#147 of 159
Health Care
What the data says
Among 159 Health Care companies, KESTRA MEDICAL TECHNOLOGIES, LTD. is in the bottom 8% for eps (diluted). EPS (Diluted) remained relatively stable over the past 3 years, with values between $-5.13 and $-5.07.
Based on SEC 10-K filings.
-5.07 in FY2025.
Remained stable around $-5.07 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 159This company -$5.07 Sector average $1.56
▼
-425.7% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 1.2% year-over-year.
- Ranks #147 out of 159 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.01 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.07 | +1.2% |
| FY2024 | -$5.13 | -1.2% |
| FY2023 | -$5.07 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026